Description
Emgality is an FDA-approved CGRP (calcitonin gene-related peptide) monoclonal antibody designed to prevent migraines and episodic cluster headaches in adults. Administered via monthly self-injection, it targets and blocks CGRP activity, a key contributor to migraine pathways.
Key Benefits:
✔ Migraine Prevention – Reduces monthly migraine days by 50% or more for many patients
✔ Cluster Headache Relief – First FDA-approved preventive treatment for episodic cluster headaches
✔ Convenient Monthly Dosing – Pre-filled auto-injector for at-home use
✔ Non-Narcotic & Non-Sedating – Unlike traditional migraine preventatives
Available through our licensed pharmacy with cold-chain shipping to ensure potency.
